Viridian Therapeutics, Inc. (LON:0K1R)
London flag London · Delayed Price · Currency is GBP · Price in USD
16.32
+0.23 (1.43%)
At close: Aug 11, 2025

Instructure Holdings Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1,0861,21389997631747
Market Cap Growth
26.72%34.89%-7.85%207.65%573.54%308.81%
Enterprise Value
82678177774128032
Last Close Price
12.7015.4016.9024.3216.1720.30
PS Ratio
4877.435028.173647.53663.46144.9461.23
PB Ratio
2.892.262.592.982.290.54
P/TBV Ratio
4.563.154.864.657.97-
EV/Sales Ratio
-3236.513150.76503.65127.7941.48
Debt / Equity Ratio
0.050.030.050.010.000.00
Asset Turnover
0.0000.000.010.020.01
Quick Ratio
10.7114.9917.9312.7314.4811.96
Current Ratio
11.0115.4318.2712.9314.6812.14
Return on Equity (ROE)
-65.88%-48.48%-56.80%-44.57%-51.61%-163.07%
Return on Assets (ROA)
-39.77%-30.32%-34.37%-26.28%-29.75%-31.36%
Return on Capital (ROIC)
-42.60%-32.26%-36.80%-28.52%-32.28%-35.04%
Earnings Yield
-18.54%-17.78%-20.76%-11.05%-18.49%-172.21%
FCF Yield
-20.81%-15.33%-16.16%-8.05%-12.79%-46.39%
Buyback Yield / Dilution
-41.68%-51.68%-39.48%-169.22%-235.07%-70.27%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.